Deep Tech Startups

Aventera Antibodies is a preclinical biotech developing a first-in-class precision immunotherapy — an engineered monoclonal antibody — against invasive Group A Streptococcal (iGAS) infections, with first-in-human trials planned for 2028. The therapy is intended to be paired with rapid Strep-A diagnostics to enable early clinical intervention.

1 investor

Avenue Biosciences operates a platform that engineers N-terminal signal peptides to modulate the secretory pathway and improve protein yield, combining high-throughput chemistry, synthetic biology, and machine learning. It targets therapeutic and biotechnology developers, optimizing expression across mammalian protein production systems including recombinant protein therapies, biosimilars, and cell and gene therapies.

1 investor

Avirmax is a preclinical-stage biopharmaceutical company developing AAV-based genetic medicines to treat chronic and degenerative ocular diseases. Through its Avirmax CMC (ACI) division, it also provides bioprocess development and manufacturing services for AAV-based gene therapies to external customers.

1 investor

Avision provides airspace infrastructure for drone operations, including FAA-approved services for airspace awareness, flight authorizations, and regulatory compliance. It serves commercial, public safety, and advanced air mobility operators such as air taxi, cargo, and emergency transportation, offering airspace coordination and traffic management for integrating drones into the national airspace.

1 investor

Avo Photonics designs, develops, and manufactures custom photonic components and systems for applications in communications, sensing, space, and defense markets. The company serves as a private-label manufacturer of client-owned photonics products.

1 investor

AXBIO builds a microfluidic Bio-CMOS platform combining nanopore sequencing, CMOS chips, and electrochemical sensors for high-throughput gene sequencing and molecular diagnostics. Its products include an EL-NGS gene sequencing platform, a multiplex nucleic acid analysis platform, and related reagents.

1 investor

Axelyf develops RNA medicines built on nanotechnology formulations and nucleic acid technologies, working across the drug development pathway from CMC and clinical pharmacology to computational sciences. The company focuses on RNA therapeutics platform development and associated therapeutic programs.

1 investor

aXenic designs, develops and manufactures optical modulators (including Mach-Zehnder modulators in Gallium Arsenide, Indium Phosphide and Lithium Niobate) for satellite, aerospace and defense communications and sensing. It offers custom device design, prototyping, packaging, testing and qualified production runs, plus engineering consultancy for high-performance optical modulators and transmitters.

1 investor

Axioforce builds portable 6-axis force plates and its Axiocell sensor technology that measure full 3D forces and moments in real time at 1000 Hz, paired with software (Flux) that computes metrics automatically. The products target athletic coaches and training environments as well as research applications.

1 investor

Axis provides risk-managed yield generation on USD, Bitcoin, and gold holdings, using delta-neutral arbitrage strategies to deliver returns without market volatility exposure. It serves investors of all sizes in the digital asset and crypto markets.

1 investor

AXISCADES provides engineering and technology solutions across aerospace, defence, and ESAI (Electronics, Semiconductor, Automotive, Industrial) sectors. The company serves clients in these industries with product engineering and infrastructure services.

1 investor

Axon Labs builds brain-inspired AI that runs on small, efficient world models at the edge to make sub-second predictions, with its first application in high-frequency trading and capital markets. The company aims to extend its real-time predictive intelligence to wearables, edge devices, robotics, and autonomous systems.

1 investor

Azkarra Therapeutics develops small molecule drugs targeting DNA damage repair and immune response pathways for cancer and inflammatory diseases. The company focuses on novel PARP inhibitors, PARG inhibitors, and OGG1 inhibitors as next-generation precision therapeutics.

1 investor

Azora develops optical ground stations for space-to-Earth data communications. The company's systems enable satellites to transmit data at significantly higher speeds and lower cost than traditional radio frequency downlinks.

1 investor

BACCH Labs develops 3D spatial audio software and filters that render existing stereo or surround content into spatial audio on standard stereo devices, headphones, and multi-speaker arrays. It licenses its IP portfolio, originating from Princeton University's 3D3A Laboratory, to B2B customers via SDKs and sells consumer software plug-ins for applications in VR/AR, automotive, gaming, cinema, and pro/consumer audio.

1 investor

Bailout Systems designs and produces hands-free descent technology intended to lower people safely in high-stakes professional environments. Its lightweight, portable devices accommodate varying speeds, line diameters, and weights for users across multiple industries.

1 investor

Ball Wave develops chemical sensing technology based on "ball SAW sensors," which use spherical quartz crystals with sensing films to measure trace moisture, hydrogen, natural gas, and organic gas mixtures. Its products include the compact gas chromatograph "Sylph," aimed at high-sensitivity, high-speed gas and vapor detection.

1 investor

Ballydel Technologies develops novel materials and manufacturing processes for use in pharmaceutical, defense, energy, and consumer goods applications.

1 investor

Baltic Sandbox Ventures is an early-stage investor and program operator running a 7-week equity-free incubation, a 6-month acceleration (Business Development Lab), and seed investments for deep-tech founders. It backs R&D-driven teams with scientific backgrounds building in domains such as AI/ML, life sciences (BioTech, MedTech), and hardware (robotics, IoT, space).

1 investor

Bandicoot Imaging provides fabric digitization and 3D texture scanning services, converting physical materials into high-resolution PBR (physically-based rendering) textures for use in 3D design tools. The service targets fashion designers, product developers, and manufacturers who need to create virtual product samples and photorealistic CGI renders without physical prototyping.

1 investor

BANIQL develops the BEST process, an atmospheric-pressure, non-HPAL route for extracting battery-grade Class 1 nickel from ore while using less energy and converting residues into fertilizer and magnesium products. It operates a pre-pilot facility in Indonesia and targets customers in the EV battery, superalloy, and related industrial nickel markets.

1 investor

Banyu Carbon develops a photochemical carbon capture process that uses sunlight to release CO2 from seawater, which naturally absorbs atmospheric carbon, for storage in geologic formations or industrial use. It aims to lower the cost of carbon removal and sell verified carbon credits to companies and governments with climate goals.

1 investor

Baobab AiBio develops therapeutics through a drug discovery pipeline (including candidates GF-103 and GF-203) using cryo-electron microscopy, protein engineering, and quantum computing. It also offers services such as structure determination, electron tomography, protein engineering, and HPC-based modeling.

1 investor

Barcode Nanotech develops nanoparticle-based delivery vehicles for RNA/DNA therapeutics and vaccines, using proprietary lipids and an in vivo and AI-based screening platform to target specific tissues and cells beyond the liver. Its platform aims at selective indications such as hard-to-treat cancers and metabolic diseases.

1 investor